[Efficacy of Low-Dose Post-Transplant Cyclophosphamide for GVHD Prophylaxis after Allogeneic Stem Cell Transplantation]
{{output}}
Objective: To evaluate the clinical efficacy and outcomes of low-dose post-transplant cyclophosphamide (PTCY) in preventing graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). ... ...
